Covered recipient · General Payments record
IAN W FLINN
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$120,219.28
- Reported across 480 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $20,965.00 | 10 |
| Food and Beverage | $1,055.61 | 32 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BeiGene USA, Inc. | $6,512.53 | 6 |
| GENZYME CORPORATION | $4,985.00 | 1 |
| ABBVIE INC. | $3,614.25 | 7 |
| Genmab U.S., Inc. | $3,024.86 | 3 |
| Genentech USA, Inc. | $2,871.31 | 2 |
| Genentech, Inc. | $380.00 | 1 |
| Amgen Inc. | $178.44 | 2 |
| Acerta Pharma LLC | $108.31 | 3 |
| Daiichi Sankyo Inc. | $88.07 | 4 |
| Celgene Corporation | $65.91 | 3 |
| Kite Pharma, Inc. | $49.30 | 2 |
| PFIZER INC. | $32.33 | 3 |
| Incyte Corporation | $26.06 | 1 |
| ADC Therapeutics America, Inc. | $23.85 | 1 |
| Astellas Pharma US Inc | $23.75 | 1 |
| SOBI, INC | $20.43 | 1 |
| Pharmacosmos Therapeutics Inc. | $16.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (42)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.01 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103736881 | CMS |
| ABBVIE INC. | $24.87 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103736883 | CMS |
| ABBVIE INC. | $142.55 | 06/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103736885 | CMS |
| ABBVIE INC. | $675.00 | 07/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103134453 | CMS |
| ABBVIE INC. | $2,700.00 | 07/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103134455 | CMS |
| ABBVIE INC. | $25.99 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103736887 | CMS |
| ABBVIE INC. | $23.83 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103736889 | CMS |
| ADC Therapeutics America, Inc. | $23.85 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121187062 | CMS |
| Amgen Inc. | $153.44 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111575644 | CMS |
| Amgen Inc. | $25.00 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111575642 | CMS |
| Astellas Pharma US Inc | $23.75 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139278582 | CMS |
| AstraZeneca Pharmaceuticals LP | $25.71 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105758083 | CMS |
| AstraZeneca Pharmaceuticals LP | $57.40 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104538236 | CMS |
| AstraZeneca Pharmaceuticals LP | $25.20 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104379995 | CMS |
| BeiGene USA, Inc. | $3,000.00 | 01/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120845317 | CMS |
| BeiGene USA, Inc. | $9.20 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120845331 | CMS |
| BeiGene USA, Inc. | $1,875.00 | 06/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120845313 | CMS |
| BeiGene USA, Inc. | $15.19 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120845336 | CMS |
| BeiGene USA, Inc. | $113.14 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120845322 | CMS |
| BeiGene USA, Inc. | $1,500.00 | 12/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120845326 | CMS |
| Celgene Corporation | $22.93 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101090159 | CMS |
| Celgene Corporation | $18.24 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101090163 | CMS |
| Celgene Corporation | $24.74 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101090201 | CMS |
| Daiichi Sankyo Inc. | $22.94 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089422072 | CMS |
| Daiichi Sankyo Inc. | $21.43 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089422070 | CMS |
| Daiichi Sankyo Inc. | $21.72 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089422074 | CMS |
| Daiichi Sankyo Inc. | $21.98 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089422076 | CMS |
| Genentech USA, Inc. | $2,850.00 | 06/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133021751 | CMS |
| Genentech USA, Inc. | $21.31 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133021755 | CMS |
| Genentech, Inc. | $380.00 | 05/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133021759 | CMS |
| Genmab U.S., Inc. | $2,250.00 | 01/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1126827260 | CMS |
| Genmab U.S., Inc. | $750.00 | 06/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1126827258 | CMS |
| Genmab U.S., Inc. | $24.86 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126827262 | CMS |
| GENZYME CORPORATION | $4,985.00 | 09/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1139601326 | CMS |
| Incyte Corporation | $26.06 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141183380 | CMS |
| Kite Pharma, Inc. | $26.20 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128611863 | CMS |
| Kite Pharma, Inc. | $23.10 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128611871 | CMS |
| PFIZER INC. | $18.98 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131108434 | CMS |
| PFIZER INC. | $12.41 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131395649 | CMS |
| PFIZER INC. | $0.94 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131395653 | CMS |
| Pharmacosmos Therapeutics Inc. | $16.21 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154821797 | CMS |
| SOBI, INC | $20.43 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141411912 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.